The Lustgarten Foundation Receives $500,000 Gift from The Warren Alpert Foundation 

The remarkable gift will support the LABS (Lustgarten Advancing Breakthrough Science) Program. 

WOODBURY, N.Y., May 1, 2024 — The Lustgarten Foundation today announced a remarkable $500,000 donation from The Warren Alpert Foundation. The generous gift will support the LABS (Lustgarten Advancing Breakthrough Science) Program, which encourages researchers to explore promising avenues for understanding and treating pancreatic cancer and improving patient outcomes.  

“We are incredibly grateful to the Warren Alpert Foundation for their continued support,” said Linda Tantawi, CEO of the Lustgarten Foundation. “Generosity is the heartbeat of progress, and this significant gift will undoubtedly fuel future breakthroughs in pancreatic cancer research.”  

Established with a vision to improve public health, The Warren Alpert Foundation honors the legacy of its founder, Warren Alpert (1920-2007), a successful entrepreneur and dedicated philanthropist. The foundation’s steadfast commitment to supporting innovative research, scholarship, and service underscores its mission to combat diseases through groundbreaking initiatives.  

“We are proud to support the cutting-edge research being done at the six LABS program sites,” said August Schiesser, the Executive Director of The Warren Alpert Foundation. “Pancreatic cancer devastates too many families, and contributing to the Lustgarten Foundation is a tangible way of making an impact.”  

A hallmark of the Lustgarten Foundation’s unique research strategy, the LABS Program provides long-term funding to promote the development of innovative ideas and speed the pace of discovery by incentivizing interdisciplinary team science. The program supports lab sites at Cold Spring Harbor Laboratory, Dana-Farber Cancer Institute, two at Johns Hopkins, MIT, and the Salk Institute for Biological Studies, fostering a community of experts to work together on the most important scientific problems that can only be solved through collaborative efforts. 

The Warren Alpert Foundation has recognized and supported the Lustgarten Foundation’s leadership in funding high-risk, high-reward pancreatic cancer research since 2019, committing $575,000 in total.